To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants.

3/18/2024, 10:18 PM

Congressional Summary of HR 7418

This bill excludes from gross income, for income tax purposes, any amount received by an individual as a qualified clinical trial payment. Such payments include amounts paid to an individual or a dependent of the individual as compensation for participation in an approved clinical trial (i.e., a trial conducted in relation to the prevention, detection, or treatment of cancer or other disease or condition) or as reimbursement or payment of reasonable and necessary expenses incurred in connection with the individual's participation in an approved clinical trial.

Current Status of Bill HR 7418

Bill HR 7418 is currently in the status of Bill Introduced since February 20, 2024. Bill HR 7418 was introduced during Congress 118 and was introduced to the House on February 20, 2024.  Bill HR 7418's most recent activity was Referred to the House Committee on Ways and Means. as of February 20, 2024

Bipartisan Support of Bill HR 7418

Total Number of Sponsors
1
Democrat Sponsors
0
Republican Sponsors
1
Unaffiliated Sponsors
0
Total Number of Cosponsors
1
Democrat Cosponsors
1
Republican Cosponsors
0
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill HR 7418

Primary Policy Focus

Taxation

Alternate Title(s) of Bill HR 7418

To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants.To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants.
Start holding our government accountable!

Comments

Sponsors and Cosponsors of HR 7418

Latest Bills

Providing for consideration of the joint resolution (S.J. Res. 18) disapproving the rule submitted by the Bureau of Consumer Financial Protection relating to "Overdraft Lending: Very Large Financial Institutions''; providing for consideration of the joint resolution (S.J. Res. 28) disapproving the rule submitted by the Bureau of Consumer Financial Protection relating to ''Defining Larger Participants of a Market for General-Use Digital Consumer Payment Applications''; providing for consideration of the bill (H.R. 1526) to amend title 28, United States Code, to limit the authority of district courts to provide injunctive relief, and for other purposes; providing for consideration of the bill (H.R. 22) to amend the National Voter Registration Act of 1993 to require proof of United States citizenship to register an individual to vote in elections for Federal office, and for other purposes; and for other purposes.
Bill HRES 282April 2, 2025
A joint resolution disapproving the rule submitted by the Bureau of Consumer Financial Protection relating to "Overdraft Lending: Very Large Financial Institutions".
Bill SJRES 18April 2, 2025
SAVE Act
Bill HR 22April 2, 2025
A joint resolution disapproving the rule submitted by the Bureau of Consumer Financial Protection relating to "Defining Larger Participants of a Market for General-Use Digital Consumer Payment Applications".
Bill SJRES 28April 2, 2025
NORRA of 2025
Bill HR 1526April 2, 2025
Expressing support for the goals and ideals of National Child Abuse Prevention Month.
Bill HRES 284April 2, 2025
Authorizing the use of Emancipation Hall in the Capitol Visitor Center for an event to celebrate the birthday of King Kamehameha I.
Bill HCONRES 24April 2, 2025
Of inquiry requesting the President to transmit certain documents relating to the dangerous, unaccountable use of AI by the United States DOGE Service to jeopardize the private information and essential services of the American people.
Bill HRES 286April 2, 2025
Expressing the sense of Congress that Trump administration tariffs on Mexico and Canada are in violation of the United States of America-Mexico-Canada Agreement.
Bill HCONRES 25April 2, 2025
Tanning Tax Repeal Act of 2025
Bill HR 1940April 2, 2025
To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants.
Bill HR 7090December 19, 2024